CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Combined use of OCT and IVUS in spontaneous coronary artery dissection Coronary Access After TAVR With a Self-Expanding Bioprosthesis: Insights From Computed Tomography 1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy) Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial

Original Research2021 Jun 12;cvab202.

JOURNAL:Cardiovasc Res. Article Link

AIM2-driven inflammasome activation in heart failure

Z Onódi, M Ruppert, D Kucsera et al. Keywords: canakinumab; cardiomyopathy; drug repurposing; heart failure; inflammation; probenecid

Full Text PDF